Monday, October 26, 2026 · Daily editionET --:--:--

Finished

Unsupervised Therapy After Stroke in the Home Setting With a Hand Rehabilitation Device (ReHandyBot)

NCT06057129 · Swiss Federal Institute of Technology · Updated 21 Sept 2026

What is being tested
Supervised and minimally-supervised therapy with ReHandyBot; Unsupervised therapy
For
Stroke
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 90 years. About 15 people. The full rules are on the registry page.
Where
Switzerland
When
Starts or started 13 Nov 2023, ends 29 May 2026. Registered 28 Sept 2023.
Results
None posted yet.

In the researchers' words

The ReHandyBot is a robot for hand rehabilitation after stroke. The aims of this study are (1) to investigate the feasibility of unsupervised therapy with the ReHandyBot with stroke inpatients, first in a rehabilitation clinic and then at participants' home, (2) to evaluate the usability of the ReHandyBot (user interface, implemented exercises, and gaming environment, which were adapted for independent usage), and (3) to quantify the dose of additional robotic therapy that patients perform without supervision. The study consists of two primary phases. The first is a familiarization phase performed at the clinic, where therapists teach to the participants how to perform the exercises with the robot. Then, if capable of training with the robot safely, after discharge from the clinic participants can bring the robot home and autonomously train with it. The hypothesis is that unsupervised therapy might be a possible way to increase therapy dose for stroke patients, with the potential to further improve recovery of hand function, with minimal additional burden for therapists and for the healthcare system.
ClinicalTrials.gov, NCT06057129

Sites

  • Clinica Hildebrand Centro di riabiliazione BrissagoBrissago, Canton Ticino, Switzerland